FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19969411000001101: Mezavant XL 1200mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Mar 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
67217101000001116 Mezavant XL 1200mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
67217201000001111 Mezavant XL 1200mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Is a Mesalazine 1.2g gastro-resistant modified-release tablets true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Is a Mezavant XL true Inferred relationship Existential restriction modifier
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mezavant XL 1200mg tablets (Lexon (UK) Ltd) 60 tablet Has AMP True Mezavant XL 1200mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start